Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strategic management of rheumatoid arthritis treatment
ChiCTR-TRC-09000469Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of leflunomide, hydroxychloroquine and methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Efficiency and recurrence rate. Started Jul 2007; status: completed.
02
Drugs
leflunomidehydroxychloroquinemethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-09000469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000469.